Wilms' tumor blastemal stem cells dedifferentiate to propagate the tumor bulk

Stem Cell Reports

Volumn 3, Issue 1, 2014, Pages 24-33

  Shukrun, Rachel ^a,c   Pode Shakked, Naomi ^a,c   Pleniceanu, Oren ^a,c   Omer, Dorit ^a,c   Vax, Einav ^a,c   Peer, Eyal ^a,c   Pri Chen, Sara ^a   Jacob, Jasmine ^a   Hu, Qianghua ^b   Harari Steinberg, Orit ^a   Huff, Vicki ^b   Dekel, Benjamin ^a,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; EPITHELIAL CELL ADHESION MOLECULE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; NERVE CELL ADHESION MOLECULE; NERVE CELL ADHESION MOLECULE 1; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SIX2; UNCLASSIFIED DRUG; UVOMORULIN; WNT PROTEIN; CD56 ANTIGEN; ISOENZYME; RETINAL DEHYDROGENASE;

ANIMAL EXPERIMENT; ARTICLE; BLASTEMA; BLASTEMAL STEM CELL; CANCER STEM CELL; CELL CYCLE ARREST; CELL DEDIFFERENTIATION; CELL HETEROGENEITY; CELL POPULATION; DEVELOPMENTAL GENE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; MOUSE; NEPHROBLASTOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL TISSUE; CARCINOGENICITY; CONTROLLED STUDY; EMBRYO; GENETIC ANALYSIS; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; SIX2 GENE; TUMOR DIFFERENTIATION; TUMOR XENOGRAFT; ANIMAL; BIOLOGICAL MODEL; CELL DIFFERENTIATION; GENETICS; KIDNEY TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; SCID MOUSE;

ANIMALS; ANTIGENS, CD56; CELL DIFFERENTIATION; FEMALE; HUMANS; ISOENZYMES; KIDNEY NEOPLASMS; MICE; MICE, SCID; MODELS, BIOLOGICAL; NEOPLASTIC STEM CELLS; RETINAL DEHYDROGENASE; WILMS TUMOR;

EID: 84904263575     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2014.05.013     Document Type: Article

References (24)

1. L. Armstrong, O. Hughes, S. Yung, L. Hyslop, R. Stewart, I. Wappler, H. Peters, T. Walter, P. Stojkovic, and J. Evans et al. The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis Hum. Mol. Genet. 15 2006 1894 1913 (Pubitemid 43821780)
2. D. Bonnet, and J.E. Dick Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat. Med. 3 1997 730 737 (Pubitemid 27298715)
3. A.C. Brown, S.D. Muthukrishnan, J.A. Guay, D.C. Adams, D.A. Schafer, J.L. Fetting, and L. Oxburgh Role for compartmentalization in nephron progenitor differentiation Proc. Natl. Acad. Sci. USA 110 2013 4640 4645
4. M.C. Cirio, E.D. de Groh, M.P. de Caestecker, A.J. Davidson, and N.A. Hukriede Kidney regeneration: common themes from the embryo to the adult Pediatr. Nephrol. 29 2014 553 564
5. B. Dekel, S. Metsuyanim, K.M. Schmidt-Ott, E. Fridman, J. Jacob-Hirsch, A. Simon, J. Pinthus, Y. Mor, J. Barasch, and N. Amariglio et al. Multiple imprinted and stemness genes provide a link between normal and tumor progenitor cells of the developing human kidney Cancer Res. 66 2006 6040 6049
6. B. Dekel, S. Metsuyanim, N. Goldstein, N. Pode-Shakked, Y. Kovalski, Y. Cohen, M. Davidovits, and Y. Anikster Schimke immuno-osseous dysplasia: expression of SMARCAL1 in blood and kidney provides novel insight into disease phenotype Pediatr. Res. 63 2008 398 403 (Pubitemid 351450586)
7. O. Harari-Steinberg, S. Metsuyanim, D. Omer, Y. Gnatek, R. Gershon, S. Pri-Chen, D.D. Ozdemir, Y. Lerenthal, T. Noiman, and H. Ben-Hur et al. Identification of human nephron progenitors capable of generation of kidney structures and functional repair of chronic renal disease EMBO Mol. Med. 5 2013 1556 1568
8. J. Huang, M. Nguyen-McCarty, E.O. Hexner, G. Danet-Desnoyers, and P.S. Klein Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways Nat. Med. 18 2012 1778 1785
9. M. Katoh, and M. Katoh WNT signaling pathway and stem cell signaling network Clin. Cancer Res. 13 2007 4042 4045 (Pubitemid 47105963)
10. A. Kobayashi, M.T. Valerius, J.W. Mugford, T.J. Carroll, M. Self, G. Oliver, and A.P. McMahon Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development Cell Stem Cell 3 2008 169 181
11. C.M. Li, M. Guo, A. Borczuk, C.A. Powell, M. Wei, H.M. Thaker, R. Friedman, U. Klein, and B. Tycko Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition Am. J. Pathol. 160 2002 2181 2190 (Pubitemid 34663409)
12. M. Little Wilms' tumor: starting off the kidney all over again? Prog. Mol. Subcell. Biol. 40 2005 107 132
13. S. Metsuyanim, O. Harari-Steinberg, E. Buzhor, D. Omer, N. Pode-Shakked, H. Ben-Hur, R. Halperin, D. Schneider, and B. Dekel Expression of stem cell markers in the human fetal kidney PLoS One 4 2009 e6709
14. K. Ohnishi, K. Semi, T. Yamamoto, M. Shimizu, A. Tanaka, K. Mitsunaga, K. Okita, K. Osafune, Y. Arioka, and T. Maeda et al. Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation Cell 156 2014 663 677
15. O. Pleniceanu, O. Harari-Steinberg, and B. Dekel Concise review: kidney stem/progenitor cells: differentiate, sort out, or reprogram? Stem Cells 28 2010 1649 1660
16. N. Pode-Shakked, and B. Dekel Wilms tumor - a renal stem cell malignancy? Pediatr. Nephrol. 26 2011 1535 1543
17. N. Pode-Shakked, R. Shukrun, M. Mark-Danieli, P. Tsvetkov, S. Bahar, S. Pri-Chen, R.S. Goldstein, E. Rom-Gross, Y. Mor, and E. Fridman et al. The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets EMBO Mol. Med. 5 2013 18 37
18. T. Reya, S.J. Morrison, M.F. Clarke, and I.L. Weissman Stem cells, cancer, and cancer stem cells Nature 414 2001 105 111 (Pubitemid 33041634)
19. M.N. Rivera, and D.A. Haber Wilms' tumour: connecting tumorigenesis and organ development in the kidney Nature reviews 5 2005 699 712 (Pubitemid 41486363)
20. B. Royer-Pokora, M. Busch, M. Beier, C. Duhme, C. de Torres, J. Mora, A. Brandt, and H.D. Royer Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm Hum. Mol. Genet. 19 2010 1651 1668
21. M. Self, O.V. Lagutin, B. Bowling, J. Hendrix, Y. Cai, G.R. Dressler, and G. Oliver Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney EMBO J. 25 2006 5214 5228 (Pubitemid 44658538)
22. K. Shostak, and A. Chariot NF-κB, stem cells and breast cancer: the links get stronger Breast Cancer Res. 13 2011 214
23. R. Shukrun, N. Pode Shakked, and B. Dekel Targeted therapy aimed at cancer stem cells: Wilms' tumor as an example Pediatr. Nephrol. 29 2014 815 823
24. S. Yano, H. Tazawa, Y. Hashimoto, Y. Shirakawa, S. Kuroda, M. Nishizaki, H. Kishimoto, F. Uno, T. Nagasaka, and Y. Urata et al. A genetically engineered oncolytic adenovirus decoys and lethally traps quiescent cancer stem-like cells in S/G2/M phases Clin. Cancer Res. 19 2013 6495 6505